Dual mTOR inhibition demonstrates antiproliferative and chemosensitizing effects in chemoresistant high-grade papillary serous ovarian cancer

被引：0
|
作者：
Musa, F. [1 ]
Giuroiu, I. [1 ]
Blank, S. [1 ]
Korets, S. [1 ]
Curtin, J. [1 ]
Schneider, R. [2 ]
机构：
[1] NYU, Langone Med Ctr, New York, NY USA
[2] NYU, Sch Med, New York, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2013年 / 131卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2013.04.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 50 条
  • [21] Principles of dormancy evident in high-grade serous ovarian cancer
    Trevor G. Shepherd
    Frederick A. Dick
    Cell Division, 17
  • [22] The peritoneal tumour microenvironment of high-grade serous ovarian cancer
    Leinster, D. Andrew
    Kulbe, Hagen
    Everitt, Gemma
    Thompson, Richard
    Perretti, Mauro
    Gavins, Felicity N. E.
    Cooper, Dianne
    Gould, David
    Ennis, Darren P.
    Lockley, Michelle
    McNeish, Iain A.
    Nourshargh, Sussan
    Balkwill, Frances R.
    JOURNAL OF PATHOLOGY, 2012, 227 (02): : 136 - 145
  • [23] Centrosomes - The Achilles' heel of high-grade serous ovarian cancer?
    Chandrasekaran, G.
    Hall, D.
    Vias, M.
    Brenton, J. D.
    Gergely, F.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [24] Determinants of resistance and response in high-grade serous ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [25] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
    Freimund, Alison E.
    Beach, Jessica A.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 983 - +
  • [26] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12): : 1169 - 1174
  • [27] Tumor immunogenicity status in high-grade serous ovarian cancer
    Berry, Laurel
    Kelly, Michael
    Miller, Lance
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S319 - S319
  • [28] Novel strategies for targeting high-grade serous ovarian cancer
    Perets, Ruth
    Wyant, Gregory A.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [29] Describing intratumoural heterogeneity in high-grade serous ovarian cancer
    Nixon, K.
    Wulandari, R.
    Curry, E.
    Rama, N.
    Bowtell, D.
    Cunnea, P.
    Fotopoulou, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 87 - 88
  • [30] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
12345